前列地尔治疗脑心综合征的疗效观察  

Effective observation of alprostadil in the treatment of cerebrocardiac syndrome

作　　者：周向东[1] 

机构地区：[1]河南省胸科医院,河南郑州450000

出　　处：《中国实用神经疾病杂志》2017年第15期99-101,共3页Chinese Journal of Practical Nervous Diseases

摘　　要：目的观察前列地尔治疗脑心综合征患者的疗效。方法选择河南省胸科医院2015-09—2016-09住院符合脑心综合征诊断标准的168例患者,随机分为观察组(84例)和对照组(84例)。2组均采用内科常规治疗,观察组采取前列地尔10μg加入0.9%氯化钠注射液100mL内静滴,bid,3周一疗程。观察2组临床疗效。结果 2组治疗后NIHSS评分显著下降,观察组较对照组明显下降(P<0.05)。BI评分显著升高,观察组较对照组明显升高(P<0.05)。2组心脏功能的疗效比较观察组明显高于对照组(P<0.05)。结论前列地尔可以提高脑心综合征患者的疗效。Objective To observe the effect of alprostadil in the treatment of patients with cerebrocardiac syndrome.Methods A total of 168 patients with cerebrocardiac syndrome were selected from Chest Hospital of Henan Province from Sep.2015 to Sep.2016,and were randomly divided into observation group（n=84）and control group（n=84）.Patients in the two groups were treated by routine medical treatment.The observation group was treated with alprostadil 10μg plus 0.9% sodium chloride injection 100 mL intravenous drip,bid,3-week was a course of treatment.Clinical curative effect was observed.ResultsNIHSS scores of the two groups were significantly decreased.The observation group decreased significantly compared with the control group（P0.05）.The BI score increased significantly,and the observation group was significantly higher than the control group（P0.05）.The efficacy of cardiac function in observation groups was significantly higher than that of control group.Conclusion Alprostadil can improve the curative effect of patients with cerebrocardiac syndrome.

关 键 词：前列地尔 脑心综合征 

分 类 号：R747.9[医药卫生—神经病学与精神病学]